Case Report: Auricular vagus nerve stimulation possibly alleviates COVID-19 disease on a high-risk patient
Introduction: SARS-CoV-2 is a highly contagious virus that was identified as the cause of COVID-19 disease in early 2020. The infection is clinically similar to interstitial pneumonia and acute respiratory distress syndrome (ARDS) and often shows cardiovascular damage. Patients with cardiovascular r...
Main Authors: | József Constantin Széles, Felix Lucny, Alexander Tyercha, Eugenijus Kaniusas, Christoph Neumayer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2022.1000194/full |
Similar Items
-
Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients
by: Tamara Seitz, et al.
Published: (2022-07-01) -
Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19
by: Tamara Seitz, et al.
Published: (2023-08-01) -
Auricular Vagus Neuromodulation—A Systematic Review on Quality of Evidence and Clinical Effects
by: Nishant Verma, et al.
Published: (2021-04-01) -
Noninvasive vagus nerve stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials
by: Dong Song, et al.
Published: (2023-05-01) -
Personalized auricular vagus nerve stimulation: beat-to-beat deceleration dominates in systole-gated stimulation during inspiration - a pilot study
by: Johannes Tischer, et al.
Published: (2025-01-01)